Cloud-Hosted
Architecture Strengthens Scalability and Efficiencies for More
Radiation Therapy Teams
Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary
of Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today
announced the release of an enhanced Cloud-hosted, SaaS option for
its SunCHECK™ Quality Management Platform. Through a centralized
database and single interface, the SunCHECK Platform streamlines
and standardizes workflows for Radiation Therapy Quality Assurance
(QA) – to reduce risk and improve Patient Safety in cancer care.
The SaaS model offers scalability, security, and operational
efficiencies for health systems looking to integrate and automate
QA, with a comprehensive, proven solution.
As demands grow within Radiation Therapy departments, clinical
and operational efficiency is essential for effective Quality
Management. The SunCHECK Platform is a secure, scalable
infrastructure built to meet the needs of any clinic type – from
single-linac sites and large academic centers to hospitals and
cancer center networks. Globally, more than 1,600 clinical users
already rely on SunCHECK software for integrated, independent
Quality Management of their Radiation Therapy programs.
Local management of software and servers can be burdensome,
requiring capital for server hardware. Cloud-hosted, SaaS
implementation of the SunCHECK Platform reduces the time and
resources required for upfront deployment and ongoing support.
SunCHECK users and their IT departments can be assured of
reliability, redundancy, and security, with Amazon Web Services as
the Cloud provider for the SunCHECK SaaS option.
“IT departments are under extreme pressure to maintain
cybersecurity and ensure operational continuity. With the new SaaS
model for the SunCHECK Platform, we’re dedicated to providing the
most robust and secure solution possible, with built-in backup and
data redundancy, plus the highest levels of data encryption, both
at rest and in-transit,” noted Andy Fuller, Sun Nuclear Director of
Product Management for the SunCHECK Platform. “As part of this
project, we challenged our team with establishing an architecture
that meets the demand for high-performance, easy implementation,
and creating a pathway for highly sought-after future
enhancements.”
“Already, we have seen how the SunCHECK Platform enables
Radiation Therapy departments to run a standardized, efficient, and
automated Quality Management program, with flexibility and
customization. We’re pleased to offer this SaaS option with
affordable subscription pricing and simple setup,” noted Eric
Schloesser, Sun Nuclear President. “Regardless of the customer’s
choice of SunCHECK implementation, via SaaS or on-premise, our
SunDEPLOYS™ team is on hand to onboard new users and set them up
for clinical success with the Platform.”
The SunCHECK SaaS solution can be customized to meet any
clinic’s radiation oncology quality management needs and is
accessed through a secure Internet connection. At this time, the
SunCHECK SaaS Solution is available for new SunCHECK Platform
customers in approved markets only.
The SunCHECK software will be featured, and available for
demonstration, in the Sun Nuclear booth during ESTRO 2022, May
6-10, in Copenhagen, Denmark. ESTRO 2022 is the annual meeting of
the European Society for Radiotherapy and Oncology, with a
membership base of 7,600 Radiation Oncology professionals
globally.
On May 17, Sun Nuclear will host an online Spring 2022 Release
Event, with insights on product updates, including the SunCHECK
Platform, and more from a comprehensive portfolio of independent,
integrated Quality Management solutions for Radiation Therapy and
Diagnostic Imaging. Learn more about the event and register to join
at: sunnuclear.com/spring22.
About the SunCHECK Platform The SunCHECK Platform enables
healthcare enterprises to streamline and automate their Patient and
Machine QA clinical workflows among staff, machines, and across
locations. The SunCHECK Patient module encompasses all parts of
Patient QA, including plan checking, secondary checks, phantomless
and array-based pre-treatment QA, and in-vivo monitoring. The
SunCHECK Machine module integrates all Machine QA needs, including
convenient template-driven comprehensive daily, monthly, annual QA,
automated imaging, MLC and VMAT QA, and data trending. Plus, with
SunDEPLOYS™, custom installation and a quick start-up are
guaranteed – for even smoother integration and clinical adoption.
Learn more at: sunnuclear.com/suncheck.
Forward-Looking Statements This press release contains
forward-looking statements within the meaning of Section 21E of the
Securities Exchange Act of 1934. Words such as “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “hope,”
“intend,” “may,” “might,” “should,” “would,” “will,” “understand”
and similar words are intended to identify forward looking
statements. These forward-looking statements include but are not
limited to, statements regarding the technology and benefits of the
Mirion product’s technology for Mirion and its customers. There are
a significant number of factors that could cause actual results to
differ materially from statements made in this press release,
including those described under the captions “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” set forth from time to time in filings and
reports we make from time to time with the Securities and Exchange
Commission, including our most recent Annual Report on form 10-K
filed February 28, 2022.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward-looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
About Mirion Mirion Technologies is a leading provider of
detection, measurement, analysis and monitoring solutions to the
nuclear, defense, medical and research end markets. The
organization aims to harness its unrivaled knowledge of ionizing
radiation for the greater good of humanity. Headquartered in
Atlanta (GA – USA), Mirion employs around 2,600 people and operates
in 13 countries. For more information, and for the latest news and
content from Mirion, visit ir.mirion.com.
About Sun Nuclear Corporation Sun Nuclear, a wholly-owned
subsidiary of Mirion Technologies, Inc. (NYSE: MIR) provides
innovative solutions for Radiation Therapy and Diagnostic Imaging
centers. Our mission is to enable healthier lives by improving the
avoidance, detection and treatment of cancer. More than 5,000
cancer centers worldwide rely on us for independent, integrated
Quality Management. With a focus on ongoing support, we aim to ease
technology adoption, enhance workflows and improve outcomes – so
that healthcare providers can achieve real results for Patient
Safety. Visit us: sunnuclear.com. Follow us: @sunnuclear.
Sun Nuclear, SunCHECK and SunDEPLOYS are trademarks of Mirion
Technologies, Inc. and/or its affiliates in the United States
and/or other countries.
Amazon Web Services, and the “Powered by AWS” logo, are
trademarks of Amazon.com, Inc. or its affiliates in the United
States and/or other countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220411005153/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Matthew Maddox
mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From May 2024 to Jun 2024
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Jun 2023 to Jun 2024